Cargando…
Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in gorlin syndrome
Nevoid basal cell carcinoma syndrome (NBCCS) is a rare autosomal dominant disorder that is due, in large measure, to aberrant Shh signaling driven by mutations in the tumor suppressor gene Ptch1. Here, we describe the development of Ptch1(+/−)/SKH-1 mice as a novel model of this disease. These anima...
Autores principales: | Chaudhary, Sandeep C., Tang, Xiuwei, Arumugam, Aadithya, Li, Changzhao, Srivastava, Ritesh K., Weng, Zhiping, Xu, Jianmin, Zhang, Xiao, Kim, Arianna L., McKay, Kristopher, Elmets, Craig A., Kopelovich, Levy, Bickers, David R., Athar, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742211/ https://www.ncbi.nlm.nih.gov/pubmed/26413810 |
Ejemplares similares
-
Inhibiting Cycloxygenase and Ornithine Decarboxylase by Diclofenac and Alpha-Difluoromethylornithine Blocks Cutaneous SCCs by Targeting Akt-ERK Axis
por: Arumugam, Aadithya, et al.
Publicado: (2013) -
Patched1 haploinsufficiency severely impacts intermediary metabolism in the skin of Ptch1(+/−)/ODC transgenic mice
por: Li, Changzhao, et al.
Publicado: (2019) -
Author Correction: Patched1 haploinsufficiency severely impacts intermediary metabolism in the skin of Ptch1(+/−)/ODC transgenic mice
por: Li, Changzhao, et al.
Publicado: (2021) -
Defining cutaneous molecular pathobiology of arsenicals using phenylarsine oxide as a prototype
por: Srivastava, Ritesh K., et al.
Publicado: (2016) -
GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis
por: Srivastava, Ritesh K., et al.
Publicado: (2014)